Last reviewed · How we verify
NCT07080502: CAPEVA
Vaginal Penetration Alteration Questionnaire
trial testing Application for the creation of a questionnaire on alterations in vaginal penetration in Female Sexual Dysfunction in 150 participants. Completed in 30 October 2023.
30 October 2023
Quick facts
| Lead sponsor | University of Castilla-La Mancha |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 June 2023 |
| Primary completion | 30 October 2023 |
| Estimated completion | 30 October 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Application for the creation of a questionnaire on alterations in vaginal penetration
Conditions studied
- Female Sexual Dysfunction — all drugs for Female Sexual Dysfunction →
Sponsor
University of Castilla-La Mancha
Who can join
Adults 18 to 60, female only, with Female Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Female sexual dysfunctions reach a prevalence of between 38 and 64%, where various factors are involved. One of the sexual dysfunctions that afflict women are those related to pelvic pain and penetration disorders that are closely related to feelings of anguish and anxiety. Due to the absence of specific, validated and reliable evaluation tools, the purpose of this work is to create an evaluation instrument for women who suffer from this dysfunction, which is self-administered and where the health professional can obtain clear and precise information about his patient. For this, an observational, multicenter study will be carried out in the city of Toledo, Spain, which consists of three large stages; The first will be the creation of domains and items through expert judgment, then a pilot will be carried out to analyze the viability and feasibility and finally the three psychometric properties will be analyzed: validity, confidence and sensitivity to change.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07080502
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Female Sexual Dysfunction
Currently open trials in the same condition.
- NCT06729151 — Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patient · recruiting
- NCT06116045 — Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder · Phase 2 · recruiting
- NCT06794346 — Sexual Effects of Transdermal or Vaginal Testosterone · Phase 2 · active not recruiting
Other University of Castilla-La Mancha trials
Trials by the same sponsor.
- NCT07487857 — Intensive Somatosensory Camp for Manual Function and Participation in Children With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07419035 — Bipolar Radiofrequency for Genitourinary Syndrome of Menopause · NA · not yet recruiting
- NCT07452172 — Lumbar and Gluteal Motor Control in Chronic Low Back Pain · NA · not yet recruiting
- NCT07041944 — HEMImprove 1.0 in Children and Adolescents With Unilateral Cerebral Palsy · NA · not yet recruiting
- NCT07091461 — HOMe-IMprove Telerrehabilitation System · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07080502 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Castilla-La Mancha
- Last refreshed: 23 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07080502.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing